Azenta (NASDAQ:AZTA - Free Report) had its price objective decreased by Evercore ISI from $64.00 to $60.00 in a research report released on Thursday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the stock.
A number of other analysts have also recently weighed in on AZTA. B. Riley raised their price objective on Azenta from $61.00 to $79.00 and gave the stock a buy rating in a research report on Thursday, February 1st. Stephens reissued an equal weight rating and issued a $70.00 price objective on shares of Azenta in a research report on Thursday, February 8th. Needham & Company LLC reissued a buy rating and issued a $75.00 price objective on shares of Azenta in a research report on Thursday, March 28th. Finally, Jefferies Financial Group began coverage on Azenta in a research report on Thursday. They issued a hold rating and a $64.00 price objective for the company. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Hold and an average price target of $69.60.
Check Out Our Latest Report on AZTA
Azenta Trading Down 1.4 %
Shares of NASDAQ:AZTA traded down $0.84 on Thursday, reaching $58.17. The company had a trading volume of 287,339 shares, compared to its average volume of 424,668. Azenta has a 52-week low of $36.01 and a 52-week high of $69.16. The firm's 50 day simple moving average is $63.22 and its 200-day simple moving average is $58.52. The firm has a market capitalization of $3.24 billion, a PE ratio of -187.65 and a beta of 1.53.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The business had revenue of $154.32 million for the quarter, compared to the consensus estimate of $151.86 million. As a group, equities research analysts predict that Azenta will post 0.28 earnings per share for the current year.
Hedge Funds Weigh In On Azenta
Several institutional investors and hedge funds have recently modified their holdings of the stock. TFC Financial Management Inc. acquired a new position in Azenta in the 3rd quarter worth about $25,000. Headlands Technologies LLC acquired a new position in Azenta in the 3rd quarter worth about $33,000. Principal Securities Inc. acquired a new position in Azenta in the 4th quarter worth about $36,000. Pinebridge Investments L.P. acquired a new position in Azenta in the 2nd quarter worth about $38,000. Finally, Northwest Financial Advisors acquired a new position in Azenta in the 4th quarter worth about $46,000. Institutional investors and hedge funds own 99.08% of the company's stock.
About Azenta
(
Get Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
